TranS1 has reported third-quarter revenues of $3.2 million, a 32 percent decreased compared to the same period last year. The spine device company also saw declines in domestic revenues and gross margin and an increase in net losses.
More Articles on Orthopedic Devices:
DePuy Launches New Trumatch Pin for Orthopedic Implants
Investors Increase Stake in Smith & Nephew
Titan Spine Appoints Marcus Klarl Vice President of Sales